Engel H, Goodacre A, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Andreeff M
YOU MUST BE 21 YEARS OF AGE OR OLDER TO USE THIS WEBSITE
How AOD 9604 (5mg) Supports Research AOD 9604 (5mg) is a research tool, not a treatment
Because adequate, well-controlled studies in pregnant individuals are lacking, use should be limited to circumstances in which the potential maternal benefit clearly outweighs theoretical fetal risk-such as treatment of documented systemic carnitine deficiency
Given the conserved chelating properties of transition metal complexes, existing clinical metal chelators can be repurposed and optimized for targeted platinum chelation, with priority given to strategies that reduce platinum accumulation in normal tissues while preserving intratumoral platinum concentrations
From this, it can be proposed that suffering from one inflammatory disorder will likely result in a chain of downstream immunological events that predisposes to the development of other ADs over time
